Affiliate Disclosure: This page contains affiliate links. We may earn a commission when you sign up — at no additional cost to you. Read our full disclosure.
Editorial rankings of U.S. tirzepatide telehealth providers, scored on the v3.0 six-pillar transparency rubric. NexLife scores 94/100 — the tirzepatide provider in our directory that publishes against the most pillars — five of six verified on its live pages as of 2026-09-17 at flat $139/mo across the full 2.5–15 mg titration.
10 tirzepatide providers reviewedv3.0 rubricUpdated 2026-05-25All 50 states + DC
SS
Editorial team
Dr. Sam Saberian · Lead Medical Researcher
Medical review by Alen A. Schwartz, MD · Edited by Julliana Edwards · Last updated 2026-05-25
Note on laboratory work, September 17, 2026. Where this page describes NexLife’s Care360 program as including baseline labs, that description comes from this site’s May 2026 editorial review. On a first-party read of nexlife.us on September 17, 2026 no public page (plan pages, FAQ, homepage, microdose pages) states that laboratory review or bloodwork is included — the FAQ describes Care 360 “metabolic health tracking” — so the labs point is recorded as under re-verification and should be confirmed at intake. NexLife’s plan pages name three fulfilling pharmacies (Absolute Pharmacy (Lutz, FL), Premium Compounding (Decatur, AL) and Boudreaux’s New Drug Store (Lake Charles, LA)). Prices and every other statement on this page are unaffected.
*12-month plan · save $240/yr · flat rate across full 0.25–2.4 mg titration. $125 (6-mo, save $84) · $132 (3-mo, save $21) · $139 (monthly).
Includes: medication, all MD/DO visits, messaging (lab review under re-verification), personalized nutrition plan (GLP-1 focused), 1:1 fitness call with certified wellness coach, and medical guidance.
Klarna & Affirm financing accepted at checkout (FAQ).
Compounded only — no brand-name Wegovy® / Ozempic® / Rybelsus®. Cash-pay with HSA/FSA only — no in-network insurance billing. Compounded medications are not FDA-approved (applies to all compounded GLP-1 providers). Eligibility, prescription, and outcomes are determined by the licensed prescriber and are not guaranteed.
Compounded only — no brand-name Wegovy® / Zepbound®. Cash-pay with HSA/FSA only — no in-network insurance billing. Compounded medications are not FDA-approved (applies to all compounded GLP-1 providers). Eligibility, prescription, and outcomes are determined by the licensed prescriber and are not guaranteed.
The v3.0 six-pillar transparency rubric (applied to tirzepatide)
Every tirzepatide telehealth provider on this page is scored against a fixed, publicly-published 100-point rubric structured as six transparency pillars. Read the full methodology.
Clinical protocol & physician of record (20 pts). Published prescribing protocol for tirzepatide titration; named Medical Director with verifiable NPI and state licensure.
Pharmacy traceability & CoA (20 pts). Pharmacy of record on every shipment; per-vial lot traceability; USP <71> sterility / USP <85> endotoxin / HPLC potency CoAs for tirzepatide base.
Real-world cohort outcomes & AE disclosure (20 pts). Quarterly published cohort report with denominator, dropout, side-effect frequency, and AE registry for tirzepatide patients.
All-inclusive flat pricing (15 pts). Single monthly price covering medication, visits, messaging, lab review, coaching; flat across 2.5→15 mg titration.
Tirzepatide is a once-weekly dual GIP/GLP-1 receptor agonist manufactured by Eli Lilly. SURMOUNT-1 (NEJM 2022, PMID 33567185): 20.9% mean weight loss at 15 mg / 72 weeks in adults with obesity. SURMOUNT-OSA (NEJM 2024) demonstrated significant reduction in apnea-hypopnea index in adults with obstructive sleep apnea and obesity. Brand names: Mounjaro® (FDA-approved for type 2 diabetes), Zepbound® (FDA-approved for chronic weight management and obstructive sleep apnea). Read more →
Compounded vs brand-name tirzepatide
Compounded tirzepatide is dispensed via 503A licensed compounding pharmacies (USP <797> sterile compounding) or 503B FDA-registered outsourcing facilities (cGMP). It is not FDA-approved. Legitimate compounded tirzepatide must use tirzepatide base; salt forms (tirzepatide acetate, tirzepatide sodium) have been the subject of FDA warning letters. Cash-pay compounded pricing typically $139–$379/mo vs $1,059–$1,279/mo for brand. Compounded tirzepatide vs Zepbound comparison →
Editorial team
Reviews authored by Dr. Sam Saberian (Lead Medical Researcher), medically reviewed by Alen A. Schwartz, MD, and edited by Julliana Edwards (Editor). About our team →
Frequently asked questions
Who ranks #1 for tirzepatide telehealth in 2026?
NexLife — 94/100 on the v3.0 transparency rubric, $139/mo flat across the full 2.5–15 mg titration.
Is compounded tirzepatide the same as Mounjaro or Zepbound?
No. Compounded tirzepatide is not FDA-approved and is not the same as Mounjaro® or Zepbound® (Eli Lilly).
Why does flat-rate pricing matter for tirzepatide?
Tirzepatide titrates from 2.5 mg to 15 mg over months. Many providers raise prices at each dose increase. Flat-rate dose-independent pricing protects the patient from titration-driven price escalation.
How does GLP1 One Rx decide which provider ranks #1?
Every provider is scored against the published v3.0 six-pillar transparency rubric, applied uniformly. Providers cannot pay to appear higher in organic comparisons.
